• Featured Product
  • KD/KO Validated

CACYBP Polyclonal antibody

CACYBP Polyclonal Antibody for WB, IHC, IF/ICC, IP, ELISA

Host / Isotype

Rabbit / IgG

Reactivity

human, mouse, rat

Applications

WB, IHC, IF/ICC, IP, ELISA

Conjugate

Unconjugated

Cat no : 11745-1-AP

Synonyms

Calcyclin, S100 alpha 6, PNAS 107, hCacyBP, GIG5



Tested Applications

Positive WB detected inHeLa cells, mouse brain tissue, mouse liver tissue, rat brain tissue, rat liver tissue
Positive IP detected inmouse brain tissue
Positive IHC detected inhuman colon cancer tissue
Note: suggested antigen retrieval with TE buffer pH 9.0; (*) Alternatively, antigen retrieval may be performed with citrate buffer pH 6.0
Positive IF/ICC detected inHeLa cells

Recommended dilution

ApplicationDilution
Western Blot (WB)WB : 1:1000-1:6000
Immunoprecipitation (IP)IP : 0.5-4.0 ug for 1.0-3.0 mg of total protein lysate
Immunohistochemistry (IHC)IHC : 1:1000-1:4000
Immunofluorescence (IF)/ICCIF/ICC : 1:50-1:500
It is recommended that this reagent should be titrated in each testing system to obtain optimal results.
Sample-dependent, Check data in validation data gallery.

Product Information

11745-1-AP targets CACYBP in WB, IHC, IF/ICC, IP, ELISA applications and shows reactivity with human, mouse, rat samples.

Tested Reactivity human, mouse, rat
Cited Reactivityhuman, mouse
Host / Isotype Rabbit / IgG
Class Polyclonal
Type Antibody
Immunogen CACYBP fusion protein Ag2340
Full Name calcyclin binding protein
Calculated Molecular Weight 228 aa, 26 kDa
Observed Molecular Weight 26-30 kDa
GenBank Accession NumberBC022352
Gene Symbol CACYBP
Gene ID (NCBI) 27101
RRIDAB_2070266
Conjugate Unconjugated
Form Liquid
Purification MethodAntigen affinity purification
Storage Buffer PBS with 0.02% sodium azide and 50% glycerol pH 7.3.
Storage ConditionsStore at -20°C. Stable for one year after shipment. Aliquoting is unnecessary for -20oC storage. 20ul sizes contain 0.1% BSA.

Background Information

CACYBP(Calcyclin-binding protein) is also named as S100A6BP, SIP. It is a new target 30 kDa protein that can interact with S100 proteins, including S100A6, S100A1, S100B, and S100P, but not to S100A4, calbindin D, parvalbumin or calmodulin(PMID:22295074). It may be involved in calcium-dependent ubiquitination and subsequent proteasomal degradation of target proteins and probably serves as a molecular bridge in ubiquitin E3 complexe. It has 2 isoforms produced by alternative splicing and can exist as a dimer(PMID:17916393).

Protocols

Product Specific Protocols
WB protocol for CACYBP antibody 11745-1-APDownload protocol
IHC protocol for CACYBP antibody 11745-1-APDownload protocol
IF protocol for CACYBP antibody 11745-1-APDownload protocol
IP protocol for CACYBP antibody 11745-1-APDownload protocol
Standard Protocols
Click here to view our Standard Protocols

Publications

SpeciesApplicationTitle
humanWB,IHC,IF

J Exp Clin Cancer Res

Blockage of CacyBP inhibits macrophage recruitment and improves anti-PD-1 therapy in hepatocellular carcinoma

Authors - Jialiang Wang
  • KD Validated
humanWB

Theranostics

CACYBP Enhances Cytoplasmic Retention of P27Kip1 to Promote Hepatocellular Carcinoma Progression in the Absence of RNF41 Mediated Degradation.

Authors - Yi-Fan Lian
  • KD Validated
mouseWB

Br J Pharmacol

A glycine-serine-alanine-rich peptide ameliorates Alzheimer-type neurodegeneration

Authors - Si-Yuan Yao
humanIF,WB

Cancer Res

MAB21L4 Deficiency Drives Squamous Cell Carcinoma via Activation of RET

Authors - Ankit Srivastava
humanWB

Am J Transl Res

Pan-analysis reveals CACYBP to be a novel prognostic and predictive marker for multiple cancers

Authors - Baosen Mo
humanWB

Carcinogenesis

CacyBP promotes the development of lung adenocarcinoma by regulating OTUD5

Authors - Mixue Bai